Top 18 CODA Biotherapeutics investors
The most complete profiles first. Showing 18 of 18.
Brian AtwoodVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsCybersecurityWomen FoundedPortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more
Verified email available
Alexander MaywegVerified
Venture Capital, Private Equity Firm · Switzerland
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Carlo Rizzuto
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more
Contact details available
Charles Warden
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more
Contact details available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Ross Jaffe
Venture Capital, Investor · United States
Series BHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Beckie Robertson
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Bill Link
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Don Milder
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Paul Grayson
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many CODA Biotherapeutics investors are on Angel Roster?
Angel Roster lists 18 CODA Biotherapeutics investors. 6 of them (33%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (13) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do CODA Biotherapeutics investors invest in?
Among those that list a stage, the most common are Seed (5) and Series B (1).
Where are CODA Biotherapeutics investors based?
Most are based in the United States (17) and Switzerland (1).
Which companies have CODA Biotherapeutics investors backed?
The most-backed portfolio companies among them are Repare Therapeutics (18), Venatorx Pharmaceuticals (9), Aligos Therapeutics (9), Intuity Medical (9) and Passage Bio (9).
How do I contact CODA Biotherapeutics investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.